The University of Texas at Austin logo

The University of Texas at Austin

North America, Texas, United States, Austin

Description

The University of Texas at Austin is a public research university providing public access to education and tools of discovery.

Investor Profile

The University of Texas at Austin has made 8 investments, with 0 in the past 12 months and 13% as lead.

Stage Focus

  • Grant (38%)
  • Seed (38%)
  • Series C (13%)
  • Series A (13%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Environmental Engineering
  • Transportation
  • Biopharma
  • Pharmaceutical
  • Communications Infrastructure
  • Infrastructure
  • Optical Communication
  • Health Care
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The University of Texas at Austin frequently co-invest with?

Fundação de Amparo à Pesquisa do Estado de SP
South America, Sao Paulo, Brazil, São Paulo
Co-Investments: 1
Columbus Venture Capital
North America, Virginia, United States, Alexandria
Co-Investments: 1
University of Chicago
North America, Illinois, United States, Chicago
Co-Investments: 1
University of Arizona
North America, Arizona, United States, Tucson
Co-Investments: 1
Startech Early Ventures
North America, Texas, United States, Richardson
Co-Investments: 1
OG
North America, Texas, United States, Dallas
Co-Investments: 1
Carnegie Institution for Science
North America, District of Columbia, United States, Washington
Co-Investments: 1
CI
North America, Texas, United States, Dallas
Co-Investments: 1
Ferocity Capital
North America, California, United States, San Francisco
Co-Investments: 1
Harvard University
North America, Massachusetts, United States, Cambridge
Co-Investments: 1

Which angels does The University of Texas at Austin often collaborate with?

Shared Deals: 1
MC
North America, Texas, United States, Austin
Shared Deals: 1
SA
North America, North Carolina, United States, Chapel Hill
Shared Deals: 1

What are some of recent deals done by The University of Texas at Austin?

Contoro Robotics

Austin, Texas, United States

Contoro Robotics combines AI and human intelligence with teleoperation.

Artificial Intelligence (AI)Information TechnologyMachinery ManufacturingRobotics
SeedMay 26, 2023
Amount Raised: $7,200,000
ClearCam

Austin, Texas, United States

ClearCam provides clinicians with innovative tools and technologies that improve their vision and skill in the operating room.

Health CareMedical DeviceProductivity Tools
SeedFeb 16, 2023
Amount Raised: $4,000,000
Jurata Thin Film

Chapel Hill, North Carolina, United States

Jurata Thin Film deals with the storage and delivery of vaccines.

Biotechnology
SeedNov 29, 2022
Amount Raised: $4,870,000
Giant Magellan Telescope Organization

Pasadena, California, United States

The ground-based Giant Magellan Telescope will be one of a next class of "Extremely Large Telescopes.

Communications InfrastructureInfrastructureOptical Communication
GrantAug 2, 2022
Amount Raised: $205,000,000
EnergyX

Fort Lauderdale, Florida, United States

EnergyX is a clean technology company that optimizes the lithium extraction process.

Chemical EngineeringEnvironmental EngineeringRenewable Energy
Series AMay 3, 2021
Amount Raised: $20,000,000
Texas Guadaloop

Austin, Texas, United States

Texas Guadaloop is a diverse group of men and women disrupting the current transportation ecosystem.

Clean EnergyPublic TransportationTransportation
GrantApr 1, 2017
Amount Raised: $10,000
AnCatt

Wilmington, Delaware, United States

AnCatt is the producer of the world's only heavy-metal free (GREEN) high-performance anti-corrosion coatings, and it out-performs others

Air TransportationEnergy EfficiencyEnvironmental EngineeringManufacturingMarine TransportationPollution ControlSustainabilityTransportation
GrantFeb 25, 2015
Amount Raised: $5,000
Reata Pharmaceuticals

Irving, Texas, United States

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

BiopharmaBiotechnologyPharmaceutical
Series CNov 12, 2004
Amount Raised: $12,000,000